He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
He will be stationed at the company HQ in Bengaluru, India
CDSCO to fast-track trials and approval for COVID19 vaccine
It is designed to tackle mental health issues
The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
Price band in the range of Rs 933 to Rs 954
The group now has 320 approvals and has so far filed over 400 ANDAs
The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.
The company is confident of commencing production at both Mahad and Chiplun units soon
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
Subscribe To Our Newsletter & Stay Updated
